If your company distributes medical devices into the European Union, two dates in late 2026 deserve immediate attention: 28 May 2026, when mandatory EUDAMED registration took effect for new devices, and 27 November 2026 — just four weeks away — the final deadline for legacy device registration. Miss the November deadline and a previously compliant product cannot legally be placed on the EU market.
These are not abstract regulatory milestones. They affect quotation validity, tender eligibility, customs clearance, and the validity of every CE certificate in a distributor's portfolio. For buyers and procurement teams evaluating suppliers, the practical question is whether your vendor can demonstrate EUDAMED registration for each SKU — not just claim compliance in general.
What the November 27 legacy device deadline actually means
When EUDAMED became fully mandatory on 28 May 2026, new MDR and IVDR devices required full registration in the UDI/Device module before placement on the EU market. The legacy device registration deadline — 27 November 2026 — closes the final gap. Any device that was placed on the market before 28 May 2026 and has not been registered by this date cannot continue to be made available, even if it holds a valid CE certificate issued by a Notified Body.
The scope is broad. It covers surgical drapes, examination gloves, wound dressings, urinary catheters, IV sets, and virtually every disposable consumable that carries a CE mark under the MDR. The requirement applies to the manufacturer's EU Authorised Representative, who must ensure that legacy devices are registered in EUDAMED before the deadline.
Registration requires the UDI/Device module to be populated with the device identifier (DI), manufacturer information, Notified Body certificate number, and clinical evaluation data. For a manufacturer with a large SKU portfolio — such as WeHere Medical's 2,500+ product lines — this is not a one-click operation. It demands structured data management and a regulatory team that can map every SKU to its UDI and certificate.
FDA user fees jump on 1 October 2026
While EUDAMED registration dominates the regulatory calendar in Europe, the United States has introduced its own cost change. Fiscal Year 2027 FDA user fees took effect on 1 October 2026, just four weeks ago. The practical impact on distributors is immediate and measurable.
A standard 510(k) premarket notification now costs USD 28,653, up from USD 26,067 in FY2026 — an increase of approximately 10%. The annual establishment registration fee rose to USD 13,785. For PMA submissions, small-business fees start at USD 144,818, and standard fees are substantially higher.
For a distributor sourcing Class II devices from multiple manufacturers, the fee increase compounds across the supply chain. Each manufacturer passes the cost through to the unit price, and the effect is visible in the FOB quotation. Buyers who have not updated their landed-cost models for the new fee schedule are effectively understating their procurement baseline.
The intersection: what distributors should do now
The EUDAMED legacy deadline and the FDA fee change are independent events, but they share a common implication for distributors: regulatory compliance is now a continuous data operation, not a periodic certification exercise. The distributors that treat it as the latter — checking CE certificates at qualification time and forgetting about it until the next audit — will find themselves caught by deadlines that arrive faster than expected.
Here is a practical framework for the next six weeks:
- Request EUDAMED registration confirmation per SKU. Ask each active supplier to confirm that every product line you purchase has been registered in the EUDAMED UDI/Device module. A blanket compliance statement is not sufficient — request the registration number and device identifier for each SKU.
- Verify legacy device coverage. For products that were on the market before 28 May 2026, confirm that the supplier's EU Authorised Representative has initiated the legacy device registration process and has a timeline for completion before 27 November 2026.
- Update landed-cost models for FDA fee changes. Any product with a US market pathway should be re-quoted with the FY2027 fee structure. The increase is not negotiable, but it should be modelled explicitly rather than absorbed as a surprise.
- Audit your regulatory documentation. Ensure that every product file contains the current CE certificate, the FDA registration number (if applicable), the EUDAMED registration status, and the UDI. If any element is missing, request it now — not when customs or a notified body asks for it.
- Plan the Class B IVDR wave. The next IVDR transition deadline — for legacy Class B and sterile Class A devices — is 26 September 2027. That date covers a far larger product universe than Class C. Starting supplier due diligence now prevents a repeat scramble in twelve months.
A manufacturer's compliance posture
At WeHere Medical, regulatory compliance is built into the production workflow rather than applied as a post-hoc certification step. Our three ISO 13485-certified factories produce to technical documentation that is structured for EU MDR and US FDA submission requirements. Every product line carries a UDI, and our regulatory team maintains the EUDAMED registration records required for both new and legacy devices.
With 2,500+ product lines across surgical dressings, examination gloves, disposable gowns, urinary drainage systems, wound care, and home-care essentials, the scale of the compliance operation is significant — but it is managed as a continuous process, not a periodic event. For distributors who need to demonstrate regulatory diligence in tenders or audits, we provide the documentation pack for every SKU on request, including CE certificates, ISO 13485 scope certificates, FDA registration confirmation, and EUDAMED registration status.
Sources
- European Commission, Regulation (EU) 2017/745 (MDR) — EUDAMED mandatory use timeline
- DNV, "EUDAMED Mandatory Use: What Manufacturers Need to Know," March 2026
- Registrar Corp, "FDA Announces New Medical Device User Fees for FY 2027," 11 August 2026
- Federal Register, "Medical Device User Fee Rates for Fiscal Year 2027," 30 July 2026
- Complizen.ai, "FDA User Fee Calculator FY2027"
